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Cytokinesis, the final step of cell division, begins with
the formation of a cleavage furrow. How the mitotic
spindle specifies the furrow at the equator in animal
cells remains unknown. Current models propose
that the concentration of the RhoGEF ECT2 at the
spindle midzone and the equatorial plasma mem-
brane directs furrow formation. Using chemical ge-
netic and optogenetic tools, we demonstrate that
the association of ECT2 with the plasma membrane
during anaphase is required and sufficient for cytoki-
nesis. Local membrane targeting of ECT2 leads to
unilateral furrowing, highlighting the importance of
local ECT2 activity. ECT2mutations that prevent cen-
tralspindlin binding compromise concentration of
ECT2 at the midzone and equatorial membrane but
sustain cytokinesis. While the association of ECT2
with the plasma membrane is essential for cytoki-
nesis, our data suggest that ECT2 recruitment to
the spindle midzone is insufficient to account for
equatorial furrowing and may act redundantly with
yet-uncharacterized signals.
INTRODUCTION
Cytokinesis is the final step of cell division that partitions sister
genomes into the two nascent daughter cells (Morgan, 2006).
Temporal and spatial regulation of cytokinesis prevents chromo-
somal instability and the unequal partitioning of organelles (Fuji-
wara et al., 2005; Ganemet al., 2007, 2009; Lacroix andMaddox,
2012). Temporal regulation is ensured by Cdk1, which inhibits
cytokinesis before anaphase onset. Spatially, the cleavage plane
needs to be positioned at the cell equator to accurately partition
sister genomes and to yield equally sized progeny (D’Avino et al.,
2015; Fededa and Gerlich, 2012; Morgan, 2006).
In animal cells, the cleavage plane is specified during
anaphase by the mitotic spindle apparatus (Burgess and Chang,2672 Cell Reports 17, 2672–2686, December 6, 2016 ª 2016 The Au
This is an open access article under the CC BY license (http://creative2005; Rappaport, 1996). Two spindle substructures are thought
to position the cytokinetic furrow at the equatorial cortex: astral
microtubules and the spindle midzone, a structure formed by
antiparallel microtubules between segregating sister genomes
in anaphase (Bringmann and Hyman, 2005; Dechant and Glot-
zer, 2003). The underlying molecular mechanisms are not well
understood. Strong evidence suggests that signals from the
mitotic spindle apparatus lead to the local activation of the small
guanosine triphosphatase (GTPase) RhoA (Jordan and Canman,
2012; Piekny et al., 2005). The active guanosine triphosphate
(GTP)-bound form of RhoA promotes contractile ring formation
and furrow ingression by simultaneous activation of actin
assembly and non-muscle myosin II activity (Bement et al.,
2005; Piekny et al., 2005; Yoshizaki et al., 2003). Experimentally
induced local RhoA activation at the plasma membrane can
induce furrowing in a spindle- and cell-cycle-independent
manner (Wagner and Glotzer, 2016), highlighting the need to un-
derstand the control of RhoA activity during cytokinesis. How the
mitotic spindle breaks cortical isotropy to generate an equatorial
contractile zone and thereby positions the cleavage plane is one
of the major unresolved questions in cell biology.
The guanine nucleotide exchange factor (GEF) activating
RhoA during cytokinesis is a conserved protein called ECT2.Mu-
tation or depletion of ECT2 prevents contractile ring assembly
and cleavage furrow formation, resulting in cytokinesis failure
(Dechant and Glotzer, 2003; Prokopenko et al., 1999; Tatsumoto
et al., 2003; Y€uce et al., 2005).
The essential cytokinetic function and properties of ECT2 (Fig-
ure 1A) put it in a central position in models of how the spindle
midzone promotes the position of the cytokinetic furrow. First,
ECT2 contains a central GEF domain that is responsible for
RhoA activation and required for cytokinesis (Prokopenko et al.,
1999; Rossman et al., 2005; Su et al., 2011). Second, ECT2
localizes to the spindle midzone upon anaphase onset via the
interaction of its N-terminal BRCA1 C-terminal (BRCT) domains
(Leung and Glover, 2011) with MgcRacGAP (also called CYK-4
or RACGAP1), a subunit of the centralspindlin complex (Mishima
et al., 2002; Pavicic-Kaltenbrunner et al., 2007; Somers and
Saint, 2003; Y€uce et al., 2005; Zhao and Fang, 2005). This
interaction requires MgcRacGAP phosphorylation by the mitoticthor(s).
commons.org/licenses/by/4.0/).
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Figure 1. Membrane Association of ECT2 Is
Essential for Cytokinesis
(A) Domain organization of AcFL-tagged and
siRNA-resistant full-length ECT2-WT protein
(reference sequence NCBI: NP_001245245) and
ECT2-C1B protein.
(B) Immunoblot analysis of protein lysates from
cells stably expressing the indicated transgenes.
Lysates were prepared 48 hr after transfection
with NTC () or ECT2 siRNA (+). The transgene is
expressed in more than 95% of cells.
(C) Live-cell imaging of ECT2-C1B proteins. Stable
cell lines expressing ECT2-C1B or ECT2-C1BQ27G
(white) were transiently transfected with H2B-
mCherry (red). Cells were imaged 48 hr after
transfection and treated with TPA at t = 0 min.
Scale bars in this and the following panels repre-
sent 10 mm.
(D) Immunofluorescence (IF) analysis of ECT2-C1B
cell lines. TPA or DMSO was added 6 hr after
transfection with ECT2 siRNA. Multi-nucleation
was analyzed 48 hr after transfection (n > 300 cells
each from three independent experiments).
(E) Live-cell imaging of indicated cell lines. Cells
were transfected with ECT2 siRNA and treated
with TPA as in (D). Cells were imaged from 24 hr
after transfection. Time point t = 0 min was set to
the metaphase-to-anaphase transition.
(F) Quantification of cytokinetic phenotypes using
live-cell imaging as described in (E). Mono-nucle-
ated cells undergoing cell division were scored
from 24 to 72 hr after transfection (n > 100 each,
bars represent mean ± SD of three independent
experiments).
See also Figure S1.kinase PLK1 (Burkard et al., 2009; Wolfe et al., 2009; Y€uce et al.,
2005). Inhibition of PLK1, as well as replacement of MgcRacGAP
with a non-phosphorylatablemutant, abrogatesECT2accumula-
tion at the spindle midzone, RhoA activation, and furrow ingres-
sion (Burkard et al., 2009; Petronczki et al., 2007; Wolfe et al.,
2009). Thus, complex formation betweenECT2andMgcRacGAP
and consecutive recruitment of the RhoGEF to the midzone are
thought to be crucial for cytokinesis. Finally, ECT2 interacts
with the plasma membrane upon anaphase onset (Chalamala-
setty et al., 2006; Su et al., 2011). This association is directed
by two C-terminal regions of ECT2, a pleckstrin homology (PH)
domain and a cluster of basic amino acids (PBC) (Figure 1A).
Deletion of these regions abrogates ECT2’s membrane recruit-
ment, RhoA activation, and cleavage furrow formation (Su
et al., 2011), indicating that the association of theRhoGEFprotein
with the cell periphery might be essential for cytokinesis. ECT2Cell Repois distributed throughout the cytoplasm
in metaphase and associates with the
plasma membrane only after anaphase
onset and CDK1 inactivation. Although
initially distributed evenly across the cell
periphery, ECT2accumulates at the equa-
torial region of the membrane at the time
of furrow ingression (Su et al., 2011). The
equatorial enrichment of ECT2was shownto require the centralspindlin complex and PLK1 enzymatic
function, both of which are essential for the spindle midzone
recruitment of the GEF protein (Y€uce et al., 2005; Petronczki
et al., 2007; Burkard et al., 2009).
Models proposed that accumulation of ECT2 to the spindle
midzone and equatorial plasma membrane could lead to
the preferential activation of RhoA and positioning of the cleav-
age furrow at the equator (D’Avino et al., 2015; Fededa and
Gerlich, 2012; Su et al., 2011). Predictions of this model are
that GEF activity, midzone association, plasma membrane
binding, and equatorial enrichment of ECT2 are essential pre-
requisites for cytokinesis. Existing data strongly support the
requirement for ECT2’s GEF activity during cytokinesis (Proko-
penko et al., 1999; Su et al., 2011). We set out to interrogate
ECT2’s association with the spindle midzone and the plasma
membrane.rts 17, 2672–2686, December 6, 2016 2673
RESULTS
Plasma Membrane Association of ECT2 Is Essential for
Cytokinesis in Human Cells
Previous work employed an ECT2 variant lacking the C-terminal
252 amino acids (ECT2-DPHDTail) to suggest that the transloca-
tion of ECT2 to the plasma membrane is a prerequisite for cyto-
kinesis (Su et al., 2011). The large deletion could compromise
other functions of the molecule and thereby contribute to the
observed phenotype. To determine whether the association of
ECT2 with the membrane is a requirement for cleavage furrow
formation in human cells, we employed a chemical genetic sys-
tem that allowed us to artificially control the association of ECT2
with the plasma membrane. The system is based on hybrid pro-
teins containing a typical C1 domain from human protein kinase
Ca (PKCa) (Colo´n-Gonza´lez and Kazanietz, 2006) that binds the
plasma membrane via interaction with diacylglycerol or phorbol
esters (Colo´n-Gonza´lez and Kazanietz, 2006; Lekomtsev et al.,
2012).
We generated a monoclonal stable HeLa Kyoto cell line ex-
pressing chimeric ECT2-C1B, in which the entire C-terminal
part of ECT2, including the PH domain and PBC, was replaced
by the C1B domain from human PKCa (Figures 1A and 1B; Fig-
ure S1A). The ECT2-C1B transgene was tagged with AcGFP
(Aequorea coerulescens GFP)-FLAG (AcFL) and was rendered
resistant to ECT2 small interfering RNA (siRNA) by inclusion of
synonymous nucleotide changes. The hybrid ECT2-C1B protein
rapidly associated with the plasma membrane in anaphase cells
after addition of the phorbol ester 12-O-tetradecanoylphorbol-
13-acetate (TPA) to the cell medium (Figure 1C; Movie S1).
Despite membrane translocation, the hybrid protein remained
detectable at the spindle midzone in anaphase cells. Mutation
of C1B glutamine 27 to glycine (Q27G) (Figure S1B), a change
predicted to disrupt the interaction with phorbolesters (Bo¨gi
et al., 1999; Colo´n-Gonza´lez and Kazanietz, 2006), abrogated
the translocation of the hybrid ECT2-C1B protein to the plasma
membrane (Figure 1C; Figures S1C–S1E; Movies S1 and S2).
To determine whether artificial membrane recruitment of ECT2
supports cytokinesis in the absence of the protein’s normally
essential native membrane engagement domains, ECT2-C1B-
expressing cells were transfected with ECT2 siRNA to deplete
endogenous protein and treated with 10 nM TPA. Multi-nucle-
ation was determined as readout for cytokinesis failure. In the
presence of the solvent, DMSO, most ECT2-C1B-expressing
cells were converted into multi-nucleated cells upon depletion
of the endogenous protein (Figure 1D). Strikingly, addition of
TPA strongly suppressed the fraction of multi-nucleated cells
(Figure 1D). TPA treatment had only a minor effect in cells ex-
pressing ECT2-C1BQ27G, indicating that the rescue effect is
dependent on TPA-induced membrane association of the C1B
domain. To assess the execution of cytokinesis directly, we
used live-cell imaging. Expression of a wild-type (WT) ECT2
transgene but not an ECT2 version lacking the PH domain and
PBC supported cell division following depletion of the endoge-
nous protein (Figures 1E and 1F). Addition of DMSO or TPA
had no significant effect on cytokinesis in these situations. TPA
addition, but not DMSO addition, allowed most ECT2-C1B-ex-
pressing cells to successfully divide, while >98% of the ECT2-2674 Cell Reports 17, 2672–2686, December 6, 2016C1BQ27G-expressing cells failed cytokinesis despite TPA addi-
tion (Figures 1E and 1F). We conclude that the interaction of
the RhoGEF ECT2 with the plasma membrane is a key property
of ECT2 that is indispensable for the execution of cytokinesis in
somatic human cells.
Plasma Membrane Association of ECT2 from Anaphase
Onward Is Required and Sufficient for Cytokinesis
The C1B hybrid system can be employed to temporally dissect
the requirement for ECT2’s association with the cell envelope.
To target ECT2 to the plasma membrane at the metaphase-to-
anaphase transition, we combined depletion of endogenous
ECT2 with cell synchronization (Figure 2A). Following the release
of ECT2-C1B-expressing cells frommetaphase, DMSOor 10 nM
TPA were added to the cell medium and cells were tracked
through cell division by live-cell imaging. While almost all
DMSO-treated cells expressing ECT2-C1B failed to undergo
cytokinesis, addition of TPA restored cell division in about half
of the cell population (Figures 2B and 2C). This rescue effect
was abolished in cells expressing the ECT2-C1BQ27G hybrid pro-
tein. The TPA-dependent rescue effect in ECT2-C1B-expressing
cells was also observed with 250 nM TPA, a concentration at
which we can clearly detect plasma membrane translocation
of the hybrid protein (Figures S2A and S2B). These data show
that the association of the RhoGEF ECT2 with the plasma mem-
brane at anaphase onset can support cleavage furrow formation
and cytokinesis.
Next, we tested whether ECT2’s engagement with the plasma
membrane only before anaphase onset supports cytokinesis.
ECT2-C1B-expressing cells were depleted of endogenous
ECT2, synchronized, and treated with DMSO or TPA from prom-
etaphase to metaphase (Figure 2D). At release into anaphase,
TPA was either removed or maintained (Figure 2D). Washout of
TPA reduced the fraction of ECT2-C1B-expressing cells that
underwent successful cytokinesis close to the fraction observed
in DMSO-treated control cells (Figure 2E). We conclude that
the association of ECT2 with the plasma membrane from
the metaphase-to-anaphase transition onward is not only suffi-
cient but also required for the execution of cell division. These
experiments define the essential time window for RhoA activa-
tion by the RhoGEF ECT2 at the plasma membrane during
cytokinesis.
Membrane Targeting of ECT2’s GEF Domain Alone
Cannot Support Cytokinesis
We next set out to determine whether the RhoGEF activity and
the ability to associate with the plasma membrane are the only
two key functions of ECT2 during cytokinesis. For these experi-
ments, a stable cell line expressing the GEF domain of ECT2
fused to the C1B domain (GEF-C1B) was generated (Figure 3A;
Figure S3A). The GEF-C1B hybrid protein rapidly and efficiently
translocated to the plasma membrane in metaphase and
anaphase cells upon treatment with TPA (Figure 3B). In contrast
to the ECT2-C1B protein (Figure 1), artificial membrane targeting
of the GEF domain alone was unable to complement the loss of
endogenous ECT2 and to accumulate at the spindle midzone
(Figures 3B and 3C). Thus, while the GEF activity of ECT2 is
essential for cell division (Prokopenko et al., 1999; Somers and
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Figure 2. Plasma Membrane Association of
ECT2 in Anaphase Is Required and Suffi-
cient to Support Cytokinesis
(A) Synchronization scheme for anaphase-specific
membrane targeting of ECT2-C1B proteins.
(B) Live-cell imaging of ECT2-C1B and ECT2-
C1BQ27G cell lines. Cells were transfected with
ECT2 siRNA and synchronized in metaphase us-
ing the protocol depicted in (A). Cells were treated
with DMSO or TPA 45 min after release from
metaphase and imaged using bright-field micro-
scopy. Time point t = 0 min was set to the meta-
phase-to-anaphase transition.
(C) Quantification of cytokinetic phenotypes of
cells recorded in (B). Mono-nucleated cells that
were in metaphase at the beginning of recording
were scored (n > 200 each, bars represent mean ±
SD of three independent experiments, Student’s
t test).
(D) Synchronization scheme for membrane tar-
geting of ECT2-C1B proteins in metaphase fol-
lowed by TPA washout before anaphase onset.
(E) Quantification of cytokinetic phenotypes of
cells treated as shown in (D). Mono-nucleated
cells that were in metaphase at the beginning
of recording were scored (n > 65 each, bars
represent mean ± SD of three independent
experiments).
See also Figure S2.Saint, 2003; Su et al., 2011; Tatsumoto et al., 2003; Y€uce et al.,
2005), the artificial targeting of the GEF domain alone to the
plasmamembrane is insufficient to support cell division. Consis-
tent with other studies (Kim et al., 2005; Wagner and Glotzer,
2016), these results suggest that the N-terminal region of ECT2
that contains the BRCT repeats and is absent in the GEF-C1B
protein might play an important role during cytokinesis.
Forced Membrane Recruitment of ECT2 and Its GEF
Domain in Metaphase Elicits Signs of Contractility
During cytokinesis, ECT2 translocates to the plasma membrane
at the time of anaphase onset when Cdk1 activity declines (Su
et al., 2011). Cdk1 activity has emerged as a potent inhibitor of
cleavage furrow formation (Niiya et al., 2005; Potapova et al.,
2006). Using the C1B hybrid system to override the control
mechanism exerted by Cdk1, we therefore tested whether
ECT2’s association with the plasma membrane restricts cleav-
age furrow formation to anaphase. We forced ECT2-C1B
and GEF-C1B fusion proteins to the plasma membrane prema-
turely in metaphase cells and scored for signs of contractility
by analyzing RhoA and the contractile ring protein anillinCell Repor(Figure 3D; Figure S3B) (Bement et al.,
2005; Liu et al., 2012; Piekny et al.,
2005; Piekny and Glotzer, 2008). We
quantified the ratio of fluorescence in-
tensity at the cell periphery and in the
cytoplasm for both proteins (Figures
S3C and S3D). We observed a small
but significant increase of anillin and
RhoA membrane signals in metaphasecells after ECT2-C1B and GEF-C1B membrane targeting (Fig-
ure 3D; Figures S3B–S3D). GEF-C1B-expressing cells also ex-
hibited signs of hypercontractility, as judged by the irregular
shape of the cell boundary (Figure 3D), a phenotype that was
not observed after ECT2-C1B membrane targeting. Consistent
with RhoA activation experiments (Wagner and Glotzer, 2016),
this suggests that preventing ECT2 membrane translocation in
metaphase contributes to restricting contractility and furrowing
activity to anaphase. Our data also provide strong support for
a role of the BRCT domains in intramolecularly restricting
RhoGEF activity of ECT2 (Kim et al., 2005).
Optogenetic Targeting of ECT2 to the Plasma
Membrane Induces Cleavage Furrow Formation
To interrogate the importance of the spatial distribution of ECT2
at the cell membrane, we expanded our analysis by employing
an optogenetic system based on the photosensitive crypto-
chrome protein (Cry2) from Arabidopsis thaliana. Upon blue-light
illumination, Cry2 changes its conformation and interacts with
the CIB1 protein, establishing an optically controlled dimeriza-
tion system (Kennedy et al., 2010).ts 17, 2672–2686, December 6, 2016 2675
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Figure 3. Membrane Targeting of ECT2’s GEF Domain Does Not Support Cytokinesis
(A) Domain organization of transgenic C1B proteins.
(B) Live-cell imaging of ECT2-C1B and GEF-C1B proteins in metaphase (upper panel) and GEF-C1B in anaphase (lower panel). Cells stably expressing the
indicated transgenes were transfected with H2B-mCherry (red) and imaged 48 hr after transfection. Cells were treated with TPA at t = 0min. The scale bars in this
and the following panels represent 10 mm.
(C) IF analysis of cells stably expressing GEF-C1B. DMSO or TPA was added to the cells 6 hr after transfection with ECT2 siRNA. Multi-nucleation was analyzed
48 hr after transfection (n > 300 cells each from three independent experiments).
(D) IF analysis of anillin in metaphase cells expressing the indicated transgenes. Cells were treated with nocodazole to enrich the population for prometaphase
cells. One hour after nocodazole washout, the cells were treated with DMSO or TPA for 5 min and analyzed. Membrane localization of ECT2 variants is largely lost
upon cell fixation.
See also Figure S3.For optogenetic targeting experiments, a cell line stably ex-
pressing the N-terminal part of CIB1 protein fused to EGFP
(CIBN-EGFP) was generated. A C-terminal CAAX prenylation
motif was added to anchor the protein at the plasma membrane
(CIBN-EGFP-CAAX) (Figure 4A). We then fused a truncated
version of ECT2 lacking the protein’s native membrane engage-
ment domains to Cry2-mCherry to create a photoresponsive
Cry2-mCh-ECT2r-DPHDTail fusion protein (Cry2-mCh-ECT2)
(Figure 4A). To test the system, we transfected CIBN-expressing
cells with Cry2-mCh-ECT2 and imaged them using confocal mi-
croscopy. Upon whole-cell illumination with a 488 nm laser, the
Cry2-mCh-ECT2 protein rapidly translocated to the plasma
membrane and co-localized with CIBN in anaphase cells (Fig-
ure 4B). Subsequently, we determined whether optogenetic tar-
geting of the Cry2-mCh-ECT2 protein to the plasma membrane
supports cleavage furrow formation and cytokinesis after deple-
tion of endogenous ECT2 protein. We induced the interaction of2676 Cell Reports 17, 2672–2686, December 6, 2016Cry2-mCh-ECT2 with plasma membrane-bound CIBN in meta-
phase or early anaphase cells by repeated illumination with a
488 nm laser in circular regions at two opposite locations
of the equatorial cortex. Upon illumination, we observed that
the Cry2-mCh-ECT2 protein was partially depleted from the
cytoplasm and rapidly translocated to the plasma membrane,
concentrating mainly at the equatorial periphery (Figure 4C;
Movie S3). In contrast, we did not detect any plasma membrane
recruitment of the fusion protein without blue-light illumination.
Strikingly, optogenetic targeting of Cry2-mCh-ECT2 to the
plasma membrane restored cleavage furrow ingression and
cytokinesis in more than 70% of cells, despite the absence of
essential membrane engagement domains of ECT2 (Figures
4C and 4D; Movie S3). Rescue activity was dependent on illumi-
nation with blue light. Membrane targeting of the control protein
Cry2-mCh was unable to rescue cytokinesis after depletion of
endogenous ECT2 with or without the blue-light activation
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Figure 4. Optogenetic Targeting of ECT2 to the Plasma Membrane Induces Cleavage Furrow Formation
(A) Schematic depiction of optogenetic targeting of Cry2-mCh-ECT2 to the plasma membrane.
(B) Frames from confocal live-cell imaging. Cells were transfected with Cry2-mCh-ECT2 and CIBN-EGFP-CAAX. Cells were imaged 48 hr post-transfection, and
the whole field was activated by scanning with a 488 nm laser at t = 0 s. Scale bars in this and the following panels represent 10 mm.
(C) Live-cell imaging with or without blue-light illumination. Cells stably expressing CIBN-EGFP-CAAX (inset) were transfected with Cry2-mCh-ECT2 and ECT2
siRNA and imaged 24 hr after siRNA transfection. Photoactivation was performed by illumination with a 488 nm laser within two small circular regions at the
equatorial periphery, as marked in the image. Cleavage furrow ingression is indicated by open arrowheads.
(D) Quantification of cytokinetic phenotypes after optogeneticmembrane targeting of ECT2 as described in (C). Metaphase or early anaphase cells with or without
blue-light illumination were scored (n = 11, Fisher’s exact test).
(legend continued on next page)
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(Figure 4D). In support of our chemical genetic experiments, the
optogenetic targeting approach demonstrates that association
of ECT2 with the plasma membrane in anaphase is a key step
for cytokinesis.
Blue-light illumination of a region close to a cell pole did not
result in the local polar accumulation of Cry2-mCh-ECT2 or polar
furrowing events (8/8 recorded cells) (Figure S4). In most cells
with polar illumination (5/8), the fusion protein accumulated at
the equator; this was accompanied by equatorial furrow forma-
tion (Figure S4). We next determined whether Cry2-mCh-ECT2
targeting to only one area of the cleavage plane causes unilateral
furrowing. Anaphase cells depleted of endogenous ECT2 were
illuminated in one region of the equatorial periphery (Figure 4E;
Movie S4). In 60% of the cells, diffusion of Cry2-mCh-ECT2
along the cell membrane or isotropic binding to the membrane
prevented unilateral accumulation of the fusion protein. This
ECT2 localization, while reminiscent of the bilateral targeting,
did not allow successful completion of cytokinesis despite bilat-
eral furrowing in a fraction of the cells (Figure 4F). In the remain-
ing 40%of cells, localized accumulation of Cry2-mCh-ECT2 was
observed at the site of unilateral illumination. Strikingly, the uni-
lateral equatorial accumulation of Cry2-mCh-ECT2 was associ-
ated with the formation of a unilateral furrow at the site of enrich-
ment of the fusion protein (Figures 4E and 4F; Movie S4). This
experiment suggests that the local activity of ECT2 at the plasma
membrane is necessary to drive cleavage furrow formation.
Mutations in the BRCT1 Domain Prevent the Interaction
of ECT2 with MgcRacGAP
Although the BRCT domain-mediated and PLK1-dependent
interaction of ECT2with its spindlemidzone anchorMgcRacGAP
is central tomodels of cleavage furrowpositioning and ingression
(Burkard et al., 2009; Petronczki et al., 2007; Suet al., 2011;Wolfe
et al., 2009; Y€uce et al., 2005), the importance of this interaction
during cytokinesis has not been tested by altering full-length
ECT2. Therefore, we sought to prevent this interaction by
mutating residues T153 and K195 in the first BRCT domain of
ECT2, which are conserved throughout different BRCT-contain-
ing proteins (Figure 5A). Structural analyses of other BRCT pro-
teins indicate the importance of these residues in coordination
of the phosphate in the BRCT-interacting peptide (Clapperton
et al., 2004; Leung and Glover, 2011). An overlay of the X-ray
structure of ECT2’s BRCT repeats (Zou et al., 2014) with the
structure of BRCA1 bound to a BACH1 phosphopeptide (Clap-
perton et al., 2004) indicates that residues T153 and K195 in
ECT2 are positioned suitably for phosphate coordination (Fig-
ure 5B). Mutation of T153 and K195 disrupts the localization of
a transiently expressed N-terminal fragment of ECT2 to the
spindle midzone and abrogates the interaction of recombinant
ECT2 BRCT domains with cellular MgcRacGAP in pull-down
experiments and with an MgcRacGAP phosphopeptide in bio-(E) Live-cell imaging with unilateral blue-light illumination. Cells stably expressin
siRNA. Cells were imaged 24 hr after siRNA transfection. Photoactivationwas indu
equatorial periphery as indicated.
(F) Quantification of the furrow formation phenotype (left) and cytokinetic phenotyp
ECT2 as described in (E). Anaphase cells were scored (n = 15).
See also Figure S4.
2678 Cell Reports 17, 2672–2686, December 6, 2016physical assays (Wolfe et al., 2009; Zou et al., 2014). To investi-
gate the role of the BRCT1 domain-mediated interaction of
ECT2 with centralspindlin in cells, we introduced T153A and
K195M mutations into a full-length siRNA-resistant and AcGFP-
FLAG-tagged ECT2 construct (AcFL-ECT2r-BRCTTK encoding
ECT2-BRCTTK) (Figure 5C). We generated cell lines stably
expressing the ECT2-BRCTTK protein at a level close to the
endogenous protein (Figures 6A and 7A). Immunoprecipitation
(IP) of AcFL-tagged transgenic ECT2 proteins from protein ex-
tracts prepared from cells synchronized in anaphase revealed
that ECT2-WT, but not ECT2-BRCTTK, was associated with
MgcRacGAP (Figure 5D). This experiment demonstrates that
the BRCT1 mutations T153A and K195M strongly inhibit the
interaction of full-length ECT2 with the centralspindlin subunit
MgcRacGAP in cell extracts.
Mutations in the BRCT1 Domain Disrupt ECT2’s Spindle
Midzone Localization and Enrichment at the Equatorial
Plasma Membrane
To investigate the functional role of the BRCT1 domain-medi-
ated interaction of ECT2 with centralspindlin during cytokinesis,
we analyzed ECT2-WT- and ECT2-BRCTTK-expressing cell lines
after depletion of endogenous ECT2 protein (Figures 5C and 6A).
To test whether the BRCT mutations T153A and K195M
abolish ECT2 localization to the spindle midzone, anaphase cells
were stained for transgenic or total ECT2 after depletion of the
endogenous counterpart. While transgenic ECT2-WT co-local-
ized with MKLP1, a subunit of the centralspindlin complex (co-
localization in 8/8 cells) (White andGlotzer, 2012), ECT2-BRCTTK
was not enriched at the spindle midzone (colocalization in 3/25
cells) (Figure 6B, upper panel). Co-staining of total ECT2 with
tubulin confirmed that ECT2-WT (24/24 cells), but not ECT2-
BRCTTK (4/36 cells), was recruited to the spindle midzone
(Figure 6B, lower panel). Thus, BRCT1 domain mutations that
prevent binding of ECT2 to MgcRacGAP abrogate ECT2’s local-
ization to the spindle midzone in fixed cells.
Subsequently, ECT2 localization was tracked through cell divi-
sion in live cells. Both ECT2-WT and ECT2-BRCTTK were distrib-
uted throughout the cytoplasm in metaphase cells (Figure 6C;
Movie S5), in contrast to a membrane-anchored MyrPalm-GFP
control protein (Figure 6D; Movie S6). After anaphase onset,
ECT2-WT accumulated at the spindle midzone, translocated to
the plasma membrane and became concentrated at the equato-
rial periphery, as described previously (Su et al., 2011). ECT2-
BRCTTK accumulated at the cell periphery with timing similar
to that of ECT2-WT. However, ECT2-BRCTTK’s localization to
spindle midzone microtubule bundles (Figures 6C and 6E) and
the protein’s enrichment at the equatorial plasma membrane
(Figures 6C and 6F) were severely compromised. Image quanti-
fication revealed residual enrichment of ECT2-BRCTTK at the
equatorial membrane when compared to the profile of theg CIBN-EGFP-CAAX (inset) were transfected with Cry2-mCh-ECT2 and ECT2
ced by unilateral illuminationwith a 488 nm laser within the circular region at the
e (right) in relation to protein distribution after unilateral membrane targeting of
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Figure 5. Mutations in the BRCT1 Domain of ECT2 Disrupt Binding to MgcRacGAP
(A) Sequence alignment of indicated human BRCT-domain containing proteins. Conserved residues T153 and K195 are highlighted.
(B) The crystal structure of the BRCT domains of ECT2 (light blue) (PDB: 4N40) (Zou et al., 2014) was alignedwith a structure of the BRCT domains of BRCA1 (gold)
bound to a BACH1 phosphopeptide (gray) (PDB: 1T15) (Clapperton et al., 2004). BRCA1 residues interacting with the phosphoserine of BACH1 and their ECT2
counterparts (T153 and K195) are highlighted. Hydrogen bonds are shown as dashed lines.
(C) Domain organization of ECT2-WT protein and ECT2-BRCTTK protein.
(D) Protein extracts prepared from cells synchronized in anaphase that stably express the indicated proteins were subjected to anti-GFP immunoprecipitation
(IP). Lysates (input) and IP fractions (203 input) were analyzed by immunoblotting.membrane-anchored marker protein MyrPalm-GFP (Figure 6F).
To quantify the equatorial accumulation of ECT2 during cytoki-
nesis, we determined the protein intensity ratio at the equatorial
membrane to the polar membrane over time (Figure S5A).
Consistent with the earlier single time point analysis (Figure 6F),
ECT2-BRCTTK showed a strongly reduced but residual equato-
rial enrichment when compared to ECT2-WT over time (Fig-
ure S5A). Also, an accumulation of ECT2 around the midbody
region following furrowing completion could be detected (Fig-
ure 6C; Movie S5). This concentration could be a consequence
of the residual enrichment of the mutant protein at the congress-
ing equatorial membranes. The MyrPalm-GFP control protein
also showed equatorial enrichment at late stages of cytokinesis
(Figure 6D; Figure S5A). This apparent equatorial accumulation
was detected slightly earlier than it was for ECT2-BRCTTK. Thisis likely caused by a difference in the speed at which cells prog-
ress through cytokinesis (Figure S5B). Thus, it is possible that the
congression of two membranes at the equator contributes to the
detected late enrichment of ECT2 at this location.
Collectively, these data demonstrate that the mutations in the
BRCT1 domain of ECT2 that disrupt binding to MgcRacGAP
(Figure 5D) abrogate the recruitment of ECT2 to the spindle mid-
zone and severely compromise the enrichment of the protein at
the equatorial plasma membrane.
ECT2-BRCTTK Supports Cytokinesis in Human Cells
To examine the importance of ECT2’s targeting to the spindle
midzone and equatorial membrane during cell division, we
determined whether the ECT2-BRCTTK transgene could support
cytokinesis. Cell lines stably expressing AcFL-tagged andCell Reports 17, 2672–2686, December 6, 2016 2679
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(legend continued on next page)
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siRNA-resistant ECT2-BRCTTK close to the level of the endoge-
nous protein were compared with cell lines stably expressing
different versions of ECT2 (Figure 7A; Figure S6A) (Su et al.,
2011). Endogenous ECT2 was depleted by siRNA transfection
(Figure 7A; Figure S6B), and the fraction of multi-nucleated cells
was analyzed as an endpoint assay for prior cytokinesis failure.
Cells expressing the AcFL tag only (AcFL), a GEF-defective
ECT2 mutant (GEF4A), or a truncated ECT2 version lacking the
PH domain and PBC (DPHDTail) were converted into multi-
nucleated cells following the depletion of endogenous ECT2
(Figure 7B). The cytokinetic defect induced by depletion of
endogenous ECT2 could be fully rescued by expression of the
wild-type ECT2 transgene. Unexpectedly, expression of the
ECT2-BRCTTK protein also potently rescued cytokinesis after
depletion of endogenous ECT2 in two independent monoclonal
cell lines (Figure 7B). Complete rescuewas furthermore obtained
using a pool of ECT2-BRCTTK transgenic cells and two additional
monoclonal cell lines (Figures S6C–S6E), suggesting that clonal
effects do not account for the observed rescue.
We next examined the phenotype of BRCT mutant-express-
ing cells using live-cell imaging (Figures 7C and 7D). The
quantification of cytokinetic phenotypes confirmed that ECT2-
BRCTTK, in contrast to other defective ECT2 alleles, supports
cytokinesis in the absence of endogenous ECT2, because
most cells divided successfully (Figure 7D). The few ECT2-
BRCTTK cells that failed to divide still formed a cleavage furrow,
which later regressed. In contrast, most cells lacking ECT2 or
expressing defective ECT2 alleles failed to form a cleavage
furrow. Thus, time-lapse studies indicate that the point muta-
tions within ECT2’s BRCT1 domain that block binding to
MgcRacGAP, abrogate midzone recruitment, and compromise
enrichment of ECT2 at the equatorial membrane (Figures 5
and 6) do not prevent cleavage furrow formation and cytokinesis
completion in most cells. Cell division in ECT2-BRCTTK cells
was still dependent on MgcRacGAP (Figure 7E), suggesting
that the ECT2-BRCTTK allele did not bypass the requirement
for MgcRacGAP during cytokinesis.
We next determined whether the BRCT1 domain mutations
and consecutive changes in ECT2 protein localization altered
the profile of the contractile ring proteins RhoA and anillin along
the periphery of anaphase cells. Depletion of endogenous ECT2
in the AcFL tag-only-expressing cells disrupted the cortical
accumulation and equatorial enrichment of RhoA and anillin
(Figure 7F). This phenotype was fully rescued in the ECT2-WT-
expressing cells. The RhoA and anillin profiles in ECT2-BRCTTK
cells were undistinguishable from the profiles observed in ECT2-
WT cells (Figure 7F).
In summary, our experiments demonstrate that ECT2-BRCTTK
supports the successful execution of cell division. This suggests
that ECT2’s BRCT domain-mediated interaction with central-(D) Live-cell imaging of cells stably expressing MyrPalm-GFP. Cells were imaged
metaphase-to-anaphase transition.
(E) Quantification of the midzone localization of ECT2-WT, ECT2-BRCTTK, and
intensity ratio between the midzone and the cytoplasm is plotted for individual c
(F) Quantification of the fluorescent intensity profile along the cell membrane of E
are plotted as the mean intensity value against the measured length (n = 6 cells
See also Figure S5.spindlin, ECT2’s bulk recruitment to the spindle midzone, and
normal enrichment at the equatorial membrane are not essential
for the correct assembly of the contractile ring and successful
execution of cytokinesis in human somatic cells.
DISCUSSION
Optogenetic activation of RhoA at the plasma membrane can
induce partial furrowing activity in a spindle- and cell-cycle-inde-
pendent manner (Wagner and Glotzer, 2016). This finding high-
lights the importance of understanding the spatial and temporal
control of RhoA activity during cytokinesis. The association of
the RhoGEF ECT2 with the spindle midzone and equatorial
plasma membrane have positioned the protein at the center of
models aiming to explain how RhoA may be activated at the
equator (Burkard et al., 2009; Fededa and Gerlich, 2012; Pet-
ronczki et al., 2007; Su et al., 2011; Wolfe et al., 2009; Y€uce
et al., 2005). Strong experimental data support the requirement
of ECT2’s GEF activity during cytokinesis (Prokopenko et al.,
1999; Rossman et al., 2005; Su et al., 2011). Here we manipu-
lated the protein’s accumulation at the plasma membrane in
space and time and disrupted the protein’s recruitment to the
spindle midzone.
Using chemical genetic and optogenetic approaches, we
show that the artificial targeting of ECT2 to the plasma mem-
brane can replace the otherwise essential role of ECT2’s native
membrane engagement domains and largely restore cytokinesis
upon depletion of the endogenous protein. Thus, the key
role of the PH domain and the polybasic cluster of ECT2 is to
mediate the translocation of ECT2 to the plasma membrane.
We conclude that the association of the RhoGEF ECT2 with
the plasma membrane is an indispensable prerequisite for
RhoA activation and cytokinesis in human cells and possibly
most other animal cells.
Cell-cycle stage-specific photoactivation and TPA addition
or washout experiments revealed that ECT2’s binding to the
plasma membrane from the metaphase-to-anaphase transition
onward is required and sufficient to support cell division. These
experiments define the essential window of activity of ECT2 at
the plasma membrane for cytokinesis.
ECT2 has been implicated in the establishment of a stiff mitotic
cell cortex and timely mitotic cell rounding (Kunda and Baum,
2009; Matthews et al., 2012). Because ECT2’s engagement
with the plasma membrane from the metaphase-to-anaphase
onward suffices to drive cytokinesis, the formation of a stiff
mitotic cell cortex during mitotic entry may not be essential for
the execution of cytokinesis later. ECT2 thus activates RhoA
for two temporally separate processes during cell division:
mitotic cell rounding during prophase and cytokinetic furrow
formation during anaphase.48 hr after transfection with H2B-mCherry. Time point t = 0 min was set to the
MyrPalm-GFP in anaphase based on live-cell imaging data. The fluorescent
ells (lines represent mean ± SD).
CT2-WT, ECT2-BRCTTK, and MyrPalm-GFP proteins in anaphase cells. Values
for ECT2-WT and MyrPalm-GFP and n = 10 cells for ECT2-BRCTTK).
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The forced premature localization of ECT2 to the plasma
membrane in metaphase increased the levels of downstream
cortical cytokinetic regulators but did not result in premature
ectopic furrow formation. Preventing the association of the
RhoGEF ECT2 with the plasma membrane likely represents
one of several parallel mechanisms by which Cdk1 prevents
cleavage furrow formation before sister genomes have been par-
titioned. Forced membrane translocation of GEF-C1B, but not
ECT2-C1B, in metaphase led to premature cortical contractility
but was unable to restore cytokinesis in cells depleted of endog-
enous ECT2. These observations support the idea that the
N-terminal part of ECT2, including the BRCT repeats, acts as
an intramolecular inhibitor of RhoGEF function (Kim et al.,
2005). Unrestrained uniform activation of RhoA around the cor-
tex during cytokinesis could provide an explanation for the failure
of GEF-C1B to restore cytokinesis upon TPA addition.
To test the spatial requirements of ECT2’s interaction with the
plasma membrane, ECT2 was targeted to one area of the equa-
torial membrane in anaphase cells using optogenetics. Most
cells in which the localized accumulation of ECT2 was observed
developed a unilateral furrow at the point of illumination. This
experiment suggests that the local presence of ECT2 at the
equatorial plasma membrane is necessary to induce cleavage
furrow formation. Because localized accumulation of ECT2 sup-
ported furrowing but not completion of cytokinesis, ECT2 and
RhoA may have to be activated all around the equatorial cortex
for successful cell division.
Illumination at the polar periphery was unable to induce ECT2
accumulation or furrowing activity at the cell pole. Instead, ECT2
accumulated at the cell equator, possibly via cytoplasmic
diffusion of the activated protein or lateral diffusion of the
CIBN-bound protein in the membrane, followed by preferential
retention at the equatorial region. This was accompanied by
equatorial furrowing in more than half of the cells. These obser-
vations suggest that ECT2’s membrane distribution could be
subject to inhibition at the cell poles or to positive feedback con-
trol at the equator, two concepts worth exploring in the future.
Artificial targeting of ECT2 to the plasma membrane resulted in
furrow formation at the equator in anaphase but not at ectopic
sites. This suggests that membrane engagement of ECT2, inFigure 7. ECT2-BRCTTK Supports Cytokinesis
(A) Immunoblot analysis of protein lysates from monoclonal cell lines stably expre
with NTC () or ECT2 siRNA (+). Endogenous ECT2 protein and transgenic AcFL-
lines express the transgenes in more than 95% of cells.
(B) IF analysis of indicated cell lines. Cells were transfected with ECT2 siRNA. M
from three independent experiments). The scale bars in this panel and the follow
(C) Representative images showing cytokinetic phenotypes for indicated cell lin
microscopy from 24 hr after siRNA transfection onward. Time point t = 0 min wa
(D) Quantification of cytokinetic phenotype from recordings in (C). Mono-nucleate
(n > 300 each, bars represent mean values of three independent experiments).
(E) Quantification of cytokinetic phenotype of cells stably expressing ECT2-BRCT
Cells were imaged with bright field microscopy from 24 hr after transfection onwa
post-transfection (n > 100 cells each, bars represent mean values of three indep
(F) IF analysis and quantification of RhoA and anillin localization in anaphase cells
with ECT2 siRNA and synchronized by thymidine release protocol. Cells were fixe
cell membrane for RhoA and anillin in anaphase cells is plotted as the ratio of
measured length (n = 15 cells, lines represent mean values).
See also Figure S6.contrast to RhoA activation (Wagner and Glotzer, 2016), is not
sufficient to drive furrowing and that ECT2 might require an acti-
vator at the cell equator.
Mutations in the first BRCT repeat of ECT2 (BRCTTK) prevent
binding of ECT2 to the centralspindlin subunit MgcRacGAP in
cell extracts and ECT2’s accumulation at the spindle midzone.
Although the mutant protein translocated to the cell periphery
with similar timing as the wild-type counterpart, its enrichment
at the equatorial membrane was also severely compromised.
This demonstrates that ECT2’s recruitment to the spindle mid-
zone depends on the BRCT domain-mediated interaction with
centralspindlin. Furthermore, the centralspindlin-ECT2 interac-
tion promotes the accumulation of RhoGEF at the equatorial
plasmamembrane. The association of ECT2 with centralspindlin
could be a key element in the molecular mechanism the mitotic
spindle uses to break cortical isotropy and define the cleavage
plane in animal cells.
Despite ECT2-BRCTTK’s altered cellular distribution in
anaphase cells, the mutated allele was able to fully support
cleavage plane specification, contractile ring assembly, cleav-
age furrow ingression, and ultimately cytokinesis. These data
indicate that the BRCT domain-mediated interaction of ECT2
with centralspindlin, as determined by co-immunoprecipitation;
the recruitment of ECT2 to the midzone; and the protein’s
normal enrichment at the equatorial plasma membrane are
not essential for cytokinesis in otherwise unperturbed human
cells.
The conclusions drawn earlier rely on data derived from an
ECT2 allele carrying the mutations T153A and K195M in the
phosphopeptide-binding groove formed by the protein’s
BRCT repeats. Structural considerations and biophysical,
cellular, and biochemical data (this work and (Wolfe et al.,
2009; Zou et al., 2014) suggest that the mutations strongly
inhibit the interaction of ECT2 with MgcRacGAP and the
spindle midzone. Additional interactions between ECT2 and
MgcRacGAP that are undetectable by co-immunoprecipitation
might exist, such as the binding of the ECT2 BRCT repeats to
non-phosphorylated MgcRacGAP (Y€uce et al., 2005) or regula-
tory interactions between the C-terminal halves of both proteins
(Zhang and Glotzer, 2015). We cannot exclude that these weakssing the indicated transgenes. Lysates were prepared 48 hr after transfection
ECT2r are indicated by open and filled arrowheads, respectively. All stable cell
ulti-nucleation levels were analyzed 48 hr after transfection (n > 300 cells each
ing panels represent 10 mm.
es after depletion of endogenous ECT2. Cells were imaged with bright field
s set to the metaphase-to-anaphase transition.
d cells undergoing cell division were scored from 24 to 48 hr post-transfection
TK and transfected with different siRNA combinations as indicated in the graph.
rd. Mono-nucleated cells undergoing cell division were scored from 24 to 60 hr
endent experiments).
expressing the AcFL tag, ECT2-WT, or ECT2-BRCTTK. Cells were transfected
d and stained 36 hr after transfection. The fluorescent intensity profile along the
the mean signal intensity at the cell periphery and the cytoplasm against the
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interactions or residual minor enrichment of ECT2 at the equa-
torial membrane and midzone contribute to the execution of
cytokinesis in ECT2-BRCTTK cells. However, given the strong
defect in protein localization, we would expect at least a partial
defect in contractile ring formation or cytokinesis in ECT2-
BRCTTK cells if midzone and equatorial membrane accumula-
tion of ECT2 were directing the contractile RhoA zone or were
essential for cytokinesis. Even such partial defects were not
observed, despite the analysis of several independent clonal
transgenic cell lines and transgenic cell pools. Furthermore,
protein depletion data, as well as the use of defective ECT2
alleles, indicate that partial depletion of the endogenous ECT2
protein does not account for the absence of a phenotype in
ECT2-BRCTTK cells.
In the light of these observations, ECT2’s recruitment to mid-
zone microtubules via MgcRacGAP and its normal enrichment
at the equatorial membrane are unlikely to be the sole or pri-
mary signal for the formation and placement of the cleavage
furrow in small somatic human cells. Previously proposed
models are insufficient to explain how the spindle midzone
stimulates equatorial furrow formation and will have to be
revised (Fededa and Gerlich, 2012; Green et al., 2012; Mierzwa
and Gerlich, 2014; Petronczki et al., 2007; Wolfe et al., 2009;
Y€uce et al., 2005). ECT2, PLK1, and MgcRacGAP are all essen-
tial for furrow formation (Bastos et al., 2012; Canman et al.,
2008; Dechant and Glotzer, 2003; Jantsch-Plunger et al.,
2000; Loria et al., 2012; Petronczki et al., 2007; Prokopenko
et al., 1999; Tatsumoto et al., 2003; Y€uce et al., 2005). However,
our data suggest that the interpretation of the relevance
of PLK1-mediated complex formation between ECT2 and
MgcRacGAP might have been simplistic (Burkard et al., 2009;
Petronczki et al., 2007; Wolfe et al., 2009). PLK1 likely has
important substrates other than MgcRacGAP, whose phos-
phorylation contributes to the initiation of cytokinesis. Further-
more, our data on ECT2-BRCTTK suggest that the non-phos-
phorylatable MgcRacGAP mutants employed previously either
affect functions of MgcRacGAP other than binding to ECT2 or
more potently inhibit the interaction with ECT2 compared with
the BRCTTK mutations.
The presence of ECT2 at the plasma membrane and its GEF
activity are both essential for cell division. Our data suggest
that the BRCT domain-dependent equatorial enrichment of
ECT2 protein may not be crucial for cytokinesis. Thus, ECT2
could be activated exclusively at the cell equator to specify the
cytokinetic furrow. Recent work has identified a role for central-
spindlin in stimulating ECT2 GEF activity toward RhoA at the
plasma membrane (Basant et al., 2015; Zhang and Glotzer,
2015). Consistent with a potential involvement of this mecha-
nism, we found that cell division driven by ECT2-BRCTTK re-
quires the function of MgcRacGAP. In C. elegans, ECT2 is not
concentrated at the equator like in human cells but distributed
evenly across the cell envelope during anaphase (Chan and
Nance, 2013; Motegi and Sugimoto, 2006). Defining a conserved
mechanism that activates ECT2 specifically at the equatorial
membrane to stimulate furrow formation could help unify models
for cytokinesis in animal species.
While our work provides insights into the spatiotemporal regu-
lation of cytokinesis, it also highlights the need to critically test2684 Cell Reports 17, 2672–2686, December 6, 2016models and to renew efforts to identify molecular mechanisms
that can explain how the mitotic spindle apparatus specifies
the cleavage plane and activates RhoA in animal cells. These
mechanismsmay act redundantly with ECT2’s equatorial enrich-
ment and involve a second signal emerging from the midzone or
astral microtubules (Bringmann and Hyman, 2005; Dechant and
Glotzer, 2003; Werner et al., 2007; Zanin et al., 2013; Zhang and
Glotzer, 2015). The generation of the ECT2-BRCTTK model, in
which the ECT2-midzone-recruitment dependent mechanism
can be selectively inactivated, could facilitate the identification
of redundant pathways in the future.
EXPERIMENTAL PROCEDURES
Additional information is provided in Supplemental Experimental Procedures.
siRNA Transfection
Reverse siRNA transfections were performed using Lipofectamine RNAiMAX
reagent (Invitrogen) according to the manufacturer’s protocol. The medium
was changed 6 hr after transfection. The final concentration of siRNA in
the medium was 20 nM. The following siRNA duplexes were used: control
siRNA (non-targeting control [NTC]) (Thermo Scientific siGenome Non-Target-
ing siRNA #1 D-001210-01 and #4 D-001210-04), ECT2 siRNA (Thermo Scien-
tific siGenome D-006450-02), and MgcRacGAP siRNA (Invitrogen Stealth
HSS120934).
Cell Synchronization and Drug Treatments
Phorbol ester treatment: 12-O-tetradecanoylphorbol-13-acetate (TPA, Sigma)
at a final concentration of 10 nM, 250 nM, or 1 mM was added to cells for
inducing the artificial membrane targeting of C1B-containing proteins. Equiv-
alent volumes of the solvent DMSO were added to control samples. For the
experiment shown in Figure 2B, cells were transfected with ECT2 siRNA and
subsequently arrested in metaphase using the proteasome inhibitor MG132
(10 mM, Sigma) as described (Figure 2A) (Petronczki et al., 2007). Then,
45 min after MG132 washout and release into anaphase, either DMSO or
10 nM TPA was added to the medium and live-cell recording was initiated.
The same protocol was followed for the experiment showed in Figure S2,
but the concentration of TPA was changed to 250 nM. The TPA washout
experiment shown in Figure 2E also followed the same protocol as described
earlier for cells treated with DMSO and TPA. For cells treated with 10 nM TPA,
along with MG132 TPA was washed away afterward, as shown in Figure 2D.
To enrich the culture formetaphase cells for the experiment shown in Figure 3D
and Figure S3B, cells were treated with 166 nM nocodazole (Sigma) for 4.5 hr.
One hour after release from nocodazole, DMSO or 1 mMTPA was added. Cells
were analyzed by immunofluorescence (IF) microscopy 5 min after DMSO or
TPA addition. To enrich for anaphase cells for IF analysis (Figures 6B and
7F), 6 hr after siRNA transfection, the cells were treated for 24 hr with
2.5 mM thymidine. The cells were released from thymidine block for 9.5 hr
and processed for IF analysis.
Co-immunoprecipitation
HeLa Kyoto cells stably expressing AcFL, ECT2-WT, and ECT2-BRCTTK were
synchronously released to anaphase as described earlier and by Petronczki
et al. (2007). Cells were collected 70min after the release fromMG132-induced
metaphase block and lysed in buffer containing 20 mMHEPES, 150 mMNaCl,
0.1% Triton X-100, 5 mMMgCl2, 1 mM DTT, 1 mM PMSF, 1 mg/mL leupeptin,
1 mg/mL pepstatin, 1 mM microcystin, and 20 mM NaF. Lysates were then
subjected to immunoprecipitation using GFP-Trap beads (Chromotek) and
analyzed by immunoblotting.
Statistical Methods
All graphs presented in this study were generated using GraphPad Prism
v.6.0a. This software was also used for the statistical analysis. All datasets
were collected as biological triplicates unless otherwise specified. Statistical
tests used in each case are defined in the figure legends.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and six movies and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2016.11.029.
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